Market Place
Sourcing Support
SaNOtize’s Board Appoints Steven Basta as New Chief Executive Officer
27 Sep 2023 //
BUSINESSWIRE
SaNOtize Announces Inaugural Scientific Advisory Board
24 Jan 2023 //
BUSINESSWIRE
SaNOtize Names John Sharp Chief Financial Officer
17 Jan 2023 //
BUSINESSWIRE
SaNOtize Announces Funding to Advance Nitric Oxide-Based Therapeutics
24 Aug 2022 //
BUSINESSWIRE
SaNOtize moves to carve new OTC market for COVID therapy
25 Jul 2022 //
FIERCEBIOTECH
SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two Days
13 Jul 2022 //
BUSINESSWIRE
SaNOtize’s Breakthrough Treatment is 99% Effective; Receives Approval in India
09 Feb 2022 //
BUSINESSWIRE
SaNOtize inks agreement with Glenmark to commercialize Nitric Oxide Nasal Spray
02 Aug 2021 //
BUSINESS WIRE
SaNOtize’s Anti-Viral Treatment Made Available in Israeli Pharmacies
07 Jul 2021 //
BUSINESSWIRE
SaNOtize Obtains Health Canada Approval to Begin Enrollment for Ph III Trials
23 Jun 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.